CIK 0001627223
- Large accelerated filer
Chemours Co
Sign in to watch- Ticker
- CC
- Exchange
- NYSE
- Industry
- Chemicals & Allied Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464845564
- Phone
- +1 302-773-1000
- Business address
- 1007 MARKET STREET, WILMINGTON, DE, 19801
- Former names
- Chemours Company, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-09 | Newman Mark President and CEO | Purchase | +7,661 | $32.63 | $250K | 266,954.57 |
| 2023-06-09 | Newman Mark President and CEO | Purchase | +7,661 | $34.63 | $265K | 266,954.57 |
| 2023-03-01 | Newman Mark President and CEO | Grant or award · Performance Stock Option (Right to Buy) | +100,200 | 100,200 | ||
| 2023-03-01 | Newman Mark President and CEO | Shares withheld for taxes | −5,248 | $34.84 | $183K | 216,118.9 |
| 2023-03-01 | Newman Mark President and CEO | Grant or award | +43,053 | 259,171.9 | ||
| 2023-03-01 | Newman Mark President and CEO | Grant or award · Stock Option (Right to Buy) | +97,656 | 97,656 | ||
| 2023-03-01 | Newman Mark President and CEO | Grant or award · Performance Stock Option (Right to Buy) | +96,277 | 96,277 | ||
| 2023-02-10 | Newman Mark President and CEO | Grant or award | +147,540 | 292,224.84 | ||
| 2023-02-10 | Newman Mark President and CEO | Shares withheld for taxes | −70,974 | $34.35 | $2.4M | 221,250.84 |
| 2022-05-05 | Newman Mark President and CEO | Exercise or conversion | +197,161 | $16.04 | $3.2M | 373,508.03 |
| 2022-05-05 | Newman Mark President and CEO | Sale | −197,161 | $40.22 | $7.9M | 176,347.03 |
| 2022-05-05 | Newman Mark President and CEO | Exercise or conversion · Stock Option (Right to Buy) | −197,161 | 0 | ||
| 2022-03-01 | Newman Mark President and CEO | Shares withheld for taxes | −1,253 | $25.98 | $33K | 156,623.06 |
| 2022-03-01 | Newman Mark President and CEO | Grant or award | +19,630 | 176,253.06 | ||
| 2022-03-01 | Newman Mark President and CEO | Grant or award · Stock Option (Right to Buy) | +206,268 | 206,268 | ||
| 2022-02-11 | Newman Mark President and CEO | Grant or award | +19,473 | 165,010.71 | ||
| 2022-02-11 | Newman Mark President and CEO | Shares withheld for taxes | −7,133 | $30.00 | $214K | 157,877.71 |
| 2021-12-02 | Newman Mark President and CEO | Exercise or conversion | +34,252 | $18.45 | $632K | 179,710.58 |
| 2021-12-02 | Newman Mark President and CEO | Sale | −34,252 | $29.94 | $1.0M | 145,458.58 |
| 2021-12-02 | Newman Mark President and CEO | Exercise or conversion · Stock Option (Right to Buy) | −34,252 | 0 |
Page 1 of 4 · 63 trades